M&G PLC increased its stake in Bristol Myers Squibb (BMY) by 1.4%, making it their ninth-largest holding, following institutional buying from other major firms. Despite missing EPS expectations, BMY exceeded revenue estimates in its latest quarterly report and raised its quarterly dividend. Analyst ratings for BMY are mixed, with a consensus “Hold” rating but some firms raising price targets and issuing “Buy” ratings.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Bristol Myers Squibb Company $BMY Shares Acquired by M&G PLC
M&G PLC increased its stake in Bristol Myers Squibb (BMY) by 1.4%, making it their ninth-largest holding, following institutional buying from other major firms. Despite missing EPS expectations, BMY exceeded revenue estimates in its latest quarterly report and raised its quarterly dividend. Analyst ratings for BMY are mixed, with a consensus “Hold” rating but some firms raising price targets and issuing “Buy” ratings.